Study of the Bioavailability of Three Hesperidin Extracts.

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 13, 2019

Primary Completion Date

March 2, 2020

Study Completion Date

March 2, 2020

Conditions
Biological Availability
Interventions
DIETARY_SUPPLEMENT

Hesperidin Pharma

Two capsules with 250 mg of sweet orange extract with a mixture of hesperidin isomers -S and -R.

DIETARY_SUPPLEMENT

Hesperidin Pharma_M

Two capsules with 250 mg of sweet orange extract each with a mixture of hesperidin isomers -S and -R and micronized.

DIETARY_SUPPLEMENT

Cardiose

Two capsules with 250 mg of sweet orange extract each with more than 90% of hesperidin as isomer -S and micronized.

Trial Locations (1)

43203

Centro Tecnológico de Nutrición y Salud (Eurecat-Reus), Reus

All Listed Sponsors
collaborator

Fundació Eurecat

OTHER

collaborator

Hospital Universitari Sant Joan de Reus

OTHER

collaborator

University Rovira i Virgili

OTHER

lead

Technological Centre of Nutrition and Health, Spain

OTHER

NCT03984916 - Study of the Bioavailability of Three Hesperidin Extracts. | Biotech Hunter | Biotech Hunter